230 related articles for article (PubMed ID: 22231974)
1. [Analysis of factors associated with changes in the oral glucose tolerance test, regardless of the values of fasting glucose].
Lauria MW; Dias IN; Soares MM; Cordeiro GV; Barbosa VE; Ramos AV
Arq Bras Endocrinol Metabol; 2011 Dec; 55(9):708-13. PubMed ID: 22231974
[TBL] [Abstract][Full Text] [Related]
2. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
[TBL] [Abstract][Full Text] [Related]
3. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
[TBL] [Abstract][Full Text] [Related]
4. Comparison of HbA1c and OGTT for the diagnosis of type 2 diabetes in children at risk of diabetes.
Kim MS; Jo DS; Lee DY
Pediatr Neonatol; 2019 Aug; 60(4):428-434. PubMed ID: 30497969
[TBL] [Abstract][Full Text] [Related]
5. Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with a pro-atherogenic lipid profile.
Andreozzi F; Mannino GC; Perticone M; Perticone F; Sesti G
Atherosclerosis; 2017 Jan; 256():15-20. PubMed ID: 27940375
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of insulin release and insulin sensitivity through oral glucose tolerance test: differences between NGT, IFG, IGT, and type 2 diabetes mellitus. A cross-sectional and follow-up study.
Pontiroli AE; Pizzocri P; Caumo A; Perseghin G; Luzi L
Acta Diabetol; 2004 Jun; 41(2):70-6. PubMed ID: 15224208
[TBL] [Abstract][Full Text] [Related]
7. Elevated 1-h post-challenge plasma glucose levels in subjects with normal glucose tolerance or impaired glucose tolerance are associated with whole blood viscosity.
Marini MA; Fiorentino TV; Andreozzi F; Mannino GC; Perticone M; Sciacqua A; Perticone F; Sesti G
Acta Diabetol; 2017 Aug; 54(8):775-784. PubMed ID: 28577138
[TBL] [Abstract][Full Text] [Related]
8. [Application of hyperglycemic clamp technique in the assessment of beta-cell function in obese individuals with glucose intolerance].
Bao YQ; Jia WP; Zhu M; Lu JX; Chen L; Xiang KS
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1781-4. PubMed ID: 15631773
[TBL] [Abstract][Full Text] [Related]
9. Abnormal glycemic profiles by CGMS in obese first-degree relatives of type 2 diabetes mellitus patients.
Madhu SV; Muduli SK; Avasthi R
Diabetes Technol Ther; 2013 Jun; 15(6):461-5. PubMed ID: 23631606
[TBL] [Abstract][Full Text] [Related]
10. Impaired glucose tolerance of pregnancy is a heterogeneous metabolic disorder as defined by the glycemic response to the oral glucose tolerance test.
Retnakaran R; Zinman B; Connelly PW; Sermer M; Hanley AJ
Diabetes Care; 2006 Jan; 29(1):57-62. PubMed ID: 16373896
[TBL] [Abstract][Full Text] [Related]
11. The risk of type 2 diabetes mellitus according to 2-h plasma glucose level: The Korean Genome and Epidemiology Study (KoGES).
Park SK; Ryoo JH; Oh CM; Choi JM; Choi YJ; Lee KO; Jung JY
Diabetes Res Clin Pract; 2018 Dec; 146():130-137. PubMed ID: 28951335
[TBL] [Abstract][Full Text] [Related]
12. Continuous glucose monitoring in cystic fibrosis patients according to the glucose tolerance.
Moreau F; Weiller MA; Rosner V; Weiss L; Hasselmann M; Pinget M; Kessler R; Kessler L
Horm Metab Res; 2008 Jul; 40(7):502-6. PubMed ID: 18415892
[TBL] [Abstract][Full Text] [Related]
13. A new non-invasive technology to screen for dysglycaemia including diabetes.
Ramachandran A; Moses A; Shetty S; Thirupurasundari CJ; Seeli AC; Snehalatha C; Singvi S; Deslypere JP
Diabetes Res Clin Pract; 2010 Jun; 88(3):302-6. PubMed ID: 20188429
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of glucose intolerance in primary hyperparathyroidism and the benefit of parathyroidectomy.
Khaleeli AA; Johnson JN; Taylor WH
Diabetes Metab Res Rev; 2007 Jan; 23(1):43-8. PubMed ID: 16703622
[TBL] [Abstract][Full Text] [Related]
15. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
[TBL] [Abstract][Full Text] [Related]
16. A CROSS-SECTIONAL STUDY OF THE ASSOCIATION BETWEEN THE 1-HOUR ORAL GLUCOSE TOLERANCE TEST AND THE METABOLIC SYNDROME IN A HIGH-RISK SAMPLE WITH IMPAIRED FASTING GLUCOSE.
Lizarzaburu-Robles JC; Torres-Aparcana L; Mansilla R; Valera J; Vargas G; Vento F; Laca J; Cornetero V; Herman WH
Endocr Pract; 2020 May; 26(5):529-534. PubMed ID: 31968195
[No Abstract] [Full Text] [Related]
17. Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.
Viswanathan V; Clementina M; Nair BM; Satyavani K
J Assoc Physicians India; 2007 Dec; 55():833-7. PubMed ID: 18405128
[TBL] [Abstract][Full Text] [Related]
18. The impact of years since menopause on the development of impaired glucose tolerance.
Wu SI; Chou P; Tsai ST
J Clin Epidemiol; 2001 Feb; 54(2):117-20. PubMed ID: 11166525
[TBL] [Abstract][Full Text] [Related]
19. [Clinical screening examination for impaired glucose tolerance: is it possible to diagnose impaired glucose tolerance without a 75g oral glucose tolerance test?].
Igarashi M
Rinsho Byori; 2012 Apr; 60(4):349-55. PubMed ID: 22686045
[TBL] [Abstract][Full Text] [Related]
20. Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.
Kanat M; Norton L; Winnier D; Jenkinson C; DeFronzo RA; Abdul-Ghani MA
Acta Diabetol; 2011 Sep; 48(3):209-17. PubMed ID: 21553243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
